Inventor · disambiguated record
Francis Xavier Wilson
Also filed as: WILSON FRANCIS · WILSON FRANCIS XAVIER
15 granted patents·8 pending applications·365 citations·filing 1997–2016
93Inventor score
Files withSUMMIT CORP PLC6HOFFMANN LA ROCHE5SUMMIT THERAPEUTICS PLC4WILSON FRANCIS2BIOMARIN IGA LTD1
Top patents by PatentIndex Score
23 records- 0192US5866684APeptidyl inhibitors of viral proteasesHOFFMANN LA ROCHE·Filed 1997·Granted Feb 2, 1999·115 cites·53 claims
- 0291US6018020AAmino acid derivativesHOFFMANN LA ROCHE·Filed 1998·Granted Jan 25, 2000·109 cites·3 claims
- 0384US6372883B1Antiviral medicamentsHOFFMANN LA ROCHE·Filed 1999·Granted Apr 16, 2002·69 cites·15 claims
- 0481US8975416B2Antibacterial compoundsDAVIS PAUL JAMES·Filed 2009·Granted Mar 10, 2015·5 cites·32 claims
- 0580US6187905B1Alpha-ketoamide derivativesHOFFMANN LA ROCHE·Filed 1999·Granted Feb 13, 2001·43 cites·320 claims
- 0677US9763925B2Antibacterial compoundsSUMMIT THERAPEUTICS PLC·Filed 2016·Granted Sep 19, 2017·2 cites·7 claims
- 0777US9314456B2Antibacterial compoundsSUMMIT THERAPEUTICS PLC·Filed 2015·Granted Apr 19, 2016·2 cites·3 claims
- 0877US7825160B2(Biphenyl) carboxylic acids and derivatives thereofCELLZOME LTD·Filed 2005·Granted Nov 2, 2010·7 cites·10 claims
- 0975US8883820B2Triazole derivatives as kinase inhibitorsWILSON FRANCIS·Filed 2007·Granted Nov 11, 2014·5 cites·27 claims
- 1073US9278091B2Compounds for the treatment of Clostridium difficile associated diseaseSUMMIT THERAPEUTICS PLC·Filed 2015·Granted Mar 8, 2016·2 cites·24 claims
- 1169US8987308B2Compounds for the treatment of Clostridium difficile-associated diseaseSUMMIT CORP PLC·Filed 2012·Granted Mar 24, 2015·2 cites·15 claims
- 1266US7557244B2Substituted biphenyl carboxylic acids and derivatives thereofORTHO MCNEIL PHARM INC·Filed 2007·Granted Jul 7, 2009·1 cites·15 claims
- 1366US6703387B2Inhibitors of HPV E1 helicase enzymeHOFFMANN LA ROCHE·Filed 2001·Granted Mar 9, 2004·3 cites·6 claims
- 1457US2011195929A1Compounds for the treatment of flaviviral infectionsSUMMIT CORP PLC·Filed 2009·Application pending·0 cites
- 1553US2011015226A1Treatment of Energy Utilization DiseaseSUMMIT CORP PLC·Filed 2009·Application pending·0 cites
- 1653US2017217983A2Compounds for the treatment of clostridium difficile associated diseaseSUMMIT THERAPEUTICS PLC·Filed 2016·Application pending·0 cites
- 1750US10842784B2Treatment of energy utilization diseaseVIDA PHARMA LTD·Filed 2015·Granted Nov 24, 2020·0 cites·20 claims
- 1846US2011237538A1Treatment of lysosomal storage disorders and other proteostatic diseasesSUMMIT CORP PLC·Filed 2009·Application pending·0 cites
- 1945US2014011841A1Treatment of energy utilization diseaseNASH ROBERT JAMES·Filed 2013·Application pending·0 cites
- 2045US2010317690A1Treatment of protein folding disordersSUMMIT CORP PLC·Filed 2008·Application pending·0 cites
- 2144US2010305120A1Compounds for treating muscular dystrophyBIOMARIN IGA LTD·Filed 2009·Application pending·0 cites
- 2239US8106236B2Triaryl compounds and derivates thereofWILSON FRANCIS·Filed 2007·Granted Jan 31, 2012·0 cites·16 claims
- 2336US2014073801A1Pyrrolidine derivatives as selective glycosidase inhibitors and uses thereofSUMMIT CORP PLC·Filed 2013·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Francis Xavier Wilson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →